Patients with relapsed or refractory solid tumors, including: Small cell lung cancer (SCLC) research hub

A Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Solid Tumors

This study is testing a new medicine, ABBV-155, by itself and with other cancer drugs called taxanes. It's for adults with certain cancers like lung or breast cancer that have come back or not responded to previous treatments.